Effect of Carum Carvi on Thyroid Hormones and TSH Level
NCT ID: NCT01471288
Last Updated: 2011-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
40 participants
INTERVENTIONAL
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group3
Normal controls
Carum Cravi
40mg/kg of body weight
Group4
Normal controls
Placebo
Placebo
Group 1
Hypothyroid patients taking levothyroxin.
Carum Cravi
40mg/kg of body weight
Group2
Hypothyroid patients taking levothyroxin
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carum Cravi
40mg/kg of body weight
Placebo
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hypothyroid patients under treatment with levothyroxin
* Normal euthyroid patients with no goiter
Exclusion Criteria
* Severe lung or gasterointestinal disease
* Heart failure or renal failure
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pharmaceutical Research Center
UNKNOWN
Mashhad University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nuclear Medicine Research Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seyed Rasoul Zakavi, MD. IBNM
Role: PRINCIPAL_INVESTIGATOR
Nuclear Medicine Research Center
Mohammad Ramezani, Ph.D., Pharm.D
Role: PRINCIPAL_INVESTIGATOR
Pharmaceutical Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nuclear Medicine Department, Ghaem Hospital
Mashhad, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Zohre Mousavi, MD, IBE
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
88498
Identifier Type: -
Identifier Source: org_study_id